CompletedNCT01265693

The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability

Studying Sudden sensorineural hearing loss

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Carmel Medical Center
Principal Investigator
Eli Zuckerman, M.D.
Liver Unit, Carmel Medical Center
Enrollment
100 target
Eligibility
18-80 years · All sexes
Timeline
20112015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01265693 on ClinicalTrials.gov

Other trials for Sudden sensorineural hearing loss

Additional recruiting or active studies for the same condition.

See all trials for Sudden sensorineural hearing loss

← Back to all trials